It’s true that contestants on American Idol make friends for life as was evidenced by a so...
One of Hollywood's most celebrated and captivating actresses is no doubt Ellen Burstyn. He...
In a new documentary chronicling her career in comedy and television, Roseanne Barr allege...
20 Palestinian children have been evacuated by the World Health Organization to receive ur...
Ben & Jerry's quietly introduced a new ice cream flavor and to say fans are excited doesn'...
Countries
Opinion
Australia's Bowling Brilliance Shines at Lord's Against South Africa
Finance Ministry Debunks MDR Speculation on UPI Transactions
Voices: Rachel Reeves sounded like she was fighting for her political life
ICG Battles Blazing Waters: Salvage Efforts Intensify on Burning Vessel
- Boston ( Middle East ) 2025/1/31
The drug, suzetrigine, made by Boston-based Vertex Pharmaceuticals and to be sold as Journavx, works only on nerves outside the brain, block...
- Gizmodo ( Middle East ) 2025/1/31
Suzetrigine prevents pain signals from reaching the brain and doesn't give an opioid-like high, making it non-addictive—but it's expensive.
- Medscape ( Middle East ) 2025/1/31
Suzetrigine selectively inhibits the NaV1.8 pain-signaling pathway in the peripheral nervous system and provides effective relief of acute p...
- Quartz ( Middle East ) 2025/1/31
Vertex Pharmaceuticals (VRTX) stock rose on Friday after the Food and Drug Administration (FDA) approved its new painkiller, the first of it...
- CBS News ( Middle East ) 2025/1/31
Federal officials approved a new type of pain drug designed to eliminate the risks of addiction and overdose associated with opioid medicat...
- The Hill ( Middle East ) 2025/1/31
The U.S. Food and Drug Administration (FDA) approved Journavx (suzetrigine) oral tablets on Thursday as a first-in-class non-opioid analgesi...
- Washington Post ( Middle East ) 2025/1/31
The drug, shown to be almost as effective as opioids for short-term pain, is the first fundamentally new kind of painkiller to win FDA appro...
- Time ( Middle East ) 2025/1/31
On Jan. 30, the U.S. Food and Drug Administration (FDA) approved a new drug called suzetrigine to treat moderate-to-severe pain. The prescri...
- Newsweek ( Middle East ) 2025/1/31
This milestone marks a breakthrough after unsuccessful attempts to develop painkillers without the addictive potential of opioids.
- Devdiscourse ( Middle East ) 2025/1/31
In a significant development, federal officials have approved a new pain management medication, Journavx, aiming to mitigate the risks assoc...
- News10NBC ( Middle East ) 2025/1/31
WASHINGTON (AP) — Federal officials on Thursday approved a new type of pain drug designed to eliminate the risks of addiction and overdose a...
- NPR ( Middle East ) 2025/1/31
The problem ingredient identified was "undeclared milk," which poses a risk to those with severe sensitivities or allergies.(Image credit: J...
- Parade 2025/1/29
A recall on Lay's potato chips has been escalated to the highest risk level by the Food and Drug Administration (FDA), multiple outlets have...
- Newsweek ( Middle East ) 2025/1/29
The peach mango-flavored frozen treat was recalled over fears of "life-threatening" allergic reactions.
- ٍٍٍSaudi Gazette ( Saudi Arabia ) 2025/1/28
Saudi Gazette reportRIYADH — Saudi Arabia has no plan to ban the sale of traditional or electronic cigarettes, according to Dr. Hisham Al-Ja...